CDMO News
Curium Completes Acquisition of Monrol to Expand Nuclear Medicine Capabilities
Curium, a global leader in nuclear medicine, has completed its acquisition of Eczacıbaşı-Monrol Nuclear Products Co. (Monrol), a nuclear medicine manufacturer based in Istanbul, Turkey. The deal enhances Curium’s capabilities in Lutetium-177 (Lu-177) production to support its pipeline of radiopharmaceutical drug candidates for
31 March 2025